Skip to search.
 TSX Down 0.85% TSX Ventures Down 0.29%

Amgen Inc. (AMGN)

-NasdaqGS
158.56 Down 1.07(0.67%) 4:00PM EST
|After Hours : 158.54 Down 0.02 (0.01%) 4:43PM EST
Add to Portfolio
Prev Close:159.63
Open:159.40
Bid:N/A
Ask:167.00 x 100
1y Target Est:176.26
Beta:0.58
Earnings Date:Apr 20 - Apr 24 (Est.)
Day's Range:157.51 - 159.40
52wk Range:108.20 - 173.14
Volume:2,334,873
Avg Vol (3m):3,601,970
Market Cap:120.32B
P/E (ttm):23.67
EPS (ttm):6.70
Div & Yield:3.16 (2.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AMGNDown 0.67%120.32B
JNJDown 0.85%284.56B
NVSDown 1.01%237.61B
TEVADown 1.22%48.10B

Key Statistics

Forward P/E (1 yr):15.10
P/S (ttm):6.04
Ex-Dividend Date:10-Feb-15

Analysts

Annual EPS Est (Dec-15) :9.29
Quarterly EPS Est (Mar-15) :2.11
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback